For renal impairment lenilomide can not be used as maintenance therapy
June 8, 2024
Maintenance therapy for multiple myeloma (MM) post-bone marrow transplant (BMT) typically involves ongoing treatment to prolong remission and improve overall survival. Here are some key points:
- Lenalidomide: Often recommended due to its effectiveness and relatively well-tolerated side effects. It has been shown to deepen Show Full Answer
Maintenance therapy for multiple myeloma (MM) post-bone marrow transplant (BMT) typically involves ongoing treatment to prolong remission and improve overall survival. Here are some key points:
- Lenalidomide: Often recommended due to its effectiveness and relatively well-tolerated side effects. It has been shown to deepen the response over time and is usually continued indefinitely as long as it is tolerated.
- Adherence: Sticking to the maintenance therapy plan is crucial for the best outcomes.
- Side Effects: Discuss potential side effects with your oncologist to manage them effectively.
Always consult with your healthcare provider to determine the best maintenance therapy for your specific situation.
June 8, 2024